MAY 30, 2021 6:10 AM PDT

Massive Genetic Study Reveals Risk Factors for Depression

WRITTEN BY: Carmen Leitch

It's estimated that 20 percent of Americans have experienced depression and that about four percent of the global population is depressed. Genetic factors are known to play some role. By analyzing genetic and health data from over a million people, researchers have now learned more about some of the genetic factors that raise the risk of depression. Depression is known to be difficult to treat, and that's partly because we don't know a lot about its biological basis This research, which relied on biobank data from the Veterans Affair's (VA) Million Veteran Program (MVP), 23andMe, and some others, may help change that. When scientists can study that much data, they can see trends that are far more difficult to discern from small groups. The findings have been reported in Nature Neuroscience.

Health science specialist Yasamin Azadzoi removes Million Veteran Program samples from a cryotank at the Boston MVP facility. / Credit: Frank Curran

"This study uncovered more of the genetic architecture of depression than was previously known," said co-primary investigator Dr. Joel Gelernter of the VA Connecticut Healthcare System and Yale University School of Medicine. "This implicates new regions of the genome for more targeted investigation and allows us to use this information to identify drugs that are currently approved for other indications and might be repurposed for treatment of depression."

This research was a genome-wide association study (GWAS), which assesses how much influence a small variation in the genetic sequence has on some trait. It's the first study to look at the impact of gene variations on depression in over one million people. The work revealed 178 genomic locations or loci that play a role in depression risk, 77 of which are newly identified. At those 178 loci, there were 223 changes in individual base pairs in the genome - single nucleotide polymorphisms or SNPs that raise a person's risk of getting depression.

The conclusions were more reliable because the findings from one database could be checked against another.

"One of the underappreciated elements of GWAS is how reproducible the findings are," explained co-lead study author Dr. Daniel Levey of the VA Connecticut Healthcare System and Yale University School of Medicine. "Now that we've achieved adequate power, we are finding great consistency in findings from different groups' study. We hope this consistency provides a stable foundation for new discoveries that can improve treatments."

Additional work confirmed previous findings that depression has some overlap with other mental disorders like anxiety, PTSD, engaging in risky behaviors, and cannabis use disorder.

"This study, like many before it, highlights the value of the MVP sample in identifying genes for common genetic traits, especially those that are important in the veteran population. Another unique value of the MVP is that it allows us to study populations other than Europeans. We didn't find nearly as much in African-ancestry subjects as in European-ancestry, but we made a good start, and our results will be of great value in future meta-analysis efforts," said Gelernter. "This is a critical advantage of the MVP."

Learn more about enrolling in the MVP here.

Hopefully, this work will be useful in the search for better treatments for depression. If we can learn more about how the genetic variations are impacting biology, we may know more about correcting the problem. There may also be existing drugs that work on these genes that could be repurposed for treating depression. A medication for amyotrophic lateral sclerosis (ALS) acts on one of the genes identified in this study, for example.

Sources: AAAS/Eurekalert! via Veterans Affairs Research Communications, Nature Neuroscience

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 23, 2022
Clinical & Molecular DX
Accelerate diagnostic development with the right supplier
JUN 23, 2022
Accelerate diagnostic development with the right supplier
Diagnostic assays like the one you’re developing are in demand. But your task isn’t simple. Set yourself up ...
JUL 07, 2022
Neuroscience
Observing Gene Expression in Real-Time in Live Mouse Brains
JUL 07, 2022
Observing Gene Expression in Real-Time in Live Mouse Brains
Scientists still have a lot to learn about how memories are created and stored in the brain. The expression of genes lea ...
JUL 16, 2022
Health & Medicine
Taste Is a Matter of Perception... And Genetics
JUL 16, 2022
Taste Is a Matter of Perception... And Genetics
In one of the first of its kind, a study involving the link between genetics and taste perceptions (bitter, salt, savory ...
JUL 19, 2022
Genetics & Genomics
There are Genetic Links Between Gut Disorders & Alzheimer's Disease
JUL 19, 2022
There are Genetic Links Between Gut Disorders & Alzheimer's Disease
New research has found that there is a genetic connection between Alzheimer's disease and gastrointestinal disorders lik ...
AUG 26, 2022
Health & Medicine
A Viral History- Cold Sores Have Been Around for How Long?
AUG 26, 2022
A Viral History- Cold Sores Have Been Around for How Long?
The herpes simplex virus, or HSV1, is one of the most pervasive viruses among humans. A new study suggests the viru ...
OCT 05, 2022
Cell & Molecular Biology
Researchers Discover Muscle Disease Starts Earlier Than Thought
OCT 05, 2022
Researchers Discover Muscle Disease Starts Earlier Than Thought
People with Duchenne muscular dystrophy (DMD) start to experience symptoms in early childhood. The disease is caused by ...
Loading Comments...